Press Releases - 2022-11-03

Date	Title	Company
03-Nov-2022	Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of FIGS, Inc. (FIGS) on Behalf of Investors	Businesswire
03-Nov-2022	Global Medical Food Research Report 2022: Understand the Role of a Medical Food in Patients' Recovery - Qualitative and Quantitative Analyses of Ingredients and Finished Products - ResearchAndMarkets.com	Businesswire
03-Nov-2022	Monocalcium/Dicalcium Phosphate Market Report 2022: Demand from the Pharmaceutical Industry Fueling Growth - ResearchAndMarkets.com	Businesswire
03-Nov-2022	More than 50 Abstracts from Incyte’s Robust Oncology Portfolio to be Featured at the 64th ASH Annual Meeting	Businesswire
03-Nov-2022	AI Proteins Secures $18.2 Million Seed Round to Pioneer High-Throughput Platform for Advanced Miniprotein Therapeutics	Businesswire
03-Nov-2022	Kezar Life Sciences Presents Positive Complete Results from the MISSION Phase 2 Trial Evaluating Zetomipzomib in Lupus Nephritis at ASN’s Kidney Week 2022 Annual Meeting	Businesswire
03-Nov-2022	Axcella to Present at the American Association for the Study of Liver Diseases (AASLD) Annual Meeting	Businesswire
03-Nov-2022	Precision BioSciences Announces Data Presentation on Effective Cell Dose and Functional Attributes of CD19 Allogeneic CAR T, Azer-Cel, at the Upcoming 2022 American Society of Hematology (ASH) Annual Meeting	Businesswire
03-Nov-2022	Global Tunable Diode Laser Market Report 2022: Featuring Yokogawa, Servomex, Ametek, Emerson Electric, ABB, Neo Monitors & More - ResearchAndMarkets.com	Businesswire
03-Nov-2022	ADC Therapeutics Announces Abstracts Accepted for Presentation at the 64th ASH Annual Meeting	Businesswire
03-Nov-2022	Prothena to Present Data on Survival Benefit Observed in Completed Phase 3 Study of Drug Candidate Birtamimab in Patients with Mayo Stage IV AL Amyloidosis at the ASH 2022 Meeting	Businesswire
03-Nov-2022	Genmab Announces Multiple Abstracts to be Presented at the 64th Annual Meeting and Exposition of the American Society of Hematology (ASH)	Businesswire
03-Nov-2022	Rocket Pharmaceuticals Announces Presentations Highlighting AAV and Lentiviral Gene Therapies at Upcoming Scientific Congresses	Businesswire
03-Nov-2022	Wugen to Present Data on WU-NK-101 for Relapsed / Refractory Acute Myelogenous Leukemia at The American Society of Hematology’s (ASH) 64th Annual Meeting	Businesswire
03-Nov-2022	Asher Bio to Present New Preclinical Data for Selective Support of CAR-T Cell Therapies by Cis-Targeted IL-2 and IL-21 Cytokines at ASH 2022	Businesswire
03-Nov-2022	Genentech to Present Data at ASH 2022 Showcasing Strength of Hematology Portfolio and Expanding Into New Areas to Address More Patient Needs	Businesswire
03-Nov-2022	BeiGene to Present Dynamic View of Development Programs for Hematologic Malignancies at 64th ASH Meeting	Businesswire
03-Nov-2022	Orum Therapeutics Announces Presentation at ASH 2022 Annual Meeting	Businesswire
03-Nov-2022	Electra Therapeutics to Highlight ELA026 in Three Presentations at the American Society of Hematology (ASH) 2022 Annual Meeting	Businesswire
03-Nov-2022	Adicet Bio Reports ASH Abstract Data from Ongoing ADI-001 Phase 1 Trial in Relapsed or Refractory Aggressive B-Cell Non-Hodgkin’s Lymphoma (NHL)	Businesswire